名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Dermata Therapeutics Inc | DRMA | NASDAQ | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
0.33725 | 0.33 | 0.355 | 0.336 | 0.3401 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/1/13 | 06:06 | EDGAR2 | Form 8-K - Current report |
2024/1/06 | 11:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/1/06 | 11:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/1/06 | 11:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2023/12/18 | 14:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2023/12/16 | 07:00 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2023/12/08 | 06:05 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
2023/11/10 | 06:09 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/11/10 | 06:08 | EDGAR2 | Form 8-K - Current report |
2023/8/11 | 05:18 | EDGAR2 | Form 8-K - Current report |
2023/8/11 | 05:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/8/04 | 05:31 | EDGAR2 | Form 8-K - Current report |